Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February
01 Febbraio 2024 - 10:05PM
Business Wire
- Presentations to be webcast on
www.exelixis.com -
Exelixis, Inc. (Nasdaq: EXEL) today announced that members of
the company’s management team will participate in fireside chats at
the following investor conferences in February:
- Guggenheim Healthcare Talks | 6th Annual Biotechnology
Conference: Exelixis is scheduled to present at 9:00 a.m. ET / 6:00
a.m. PT on Thursday, February 8 in New York City.
- Oppenheimer 34th Annual Healthcare Life Sciences Conference:
Exelixis is scheduled to present virtually at 12:40 p.m. ET / 9:40
a.m. PT on Tuesday, February 13.
To access the webcast links, log onto www.exelixis.com and
proceed to the Event Calendar page under the Investors & News
heading. Replays will also be available at the same location for at
least 30 days.
About Exelixis
Exelixis is a globally ambitious oncology company innovating
next-generation medicines and regimens at the forefront of cancer
care. Powered by drug discovery and development excellence, we are
rapidly evolving our product portfolio to target an expanding range
of tumor types and indications with our clinically differentiated
pipeline of small molecules, antibody-drug conjugates and other
biotherapeutics. This comprehensive approach harnesses decades of
robust investment in our science and partnerships to advance our
investigational programs and extend the impact of our flagship
commercial product, CABOMETYX® (cabozantinib). Exelixis is driven
by a bold scientific pursuit to create transformational treatments
that give more patients hope for the future. For information about
the company and its mission to help cancer patients recover
stronger and live longer, visit www.exelixis.com, follow
@ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and
follow Exelixis on LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are
registered U.S. trademarks.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201568516/en/
Investors Contact: Varant Shirvanian Associate Director,
Investor Relations Exelixis, Inc. 650-837-8194
vshirvanian@exelixis.com
Media Contact: Hal Mackins For Exelixis, Inc.
415-994-0040 hal@torchcommunications.com
Grafico Azioni Exelixis (NASDAQ:EXEL)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Exelixis (NASDAQ:EXEL)
Storico
Da Gen 2024 a Gen 2025
